The study investigates the cellular expression of kynurenine aminotransferases (KAT I and II) in the rat retina during development. At P1 (the day of birth) and P7 (the 7th day after birth), KAT I expression was observed in the inner plexiform layer (IPL), the fiber layer (FL), and in vertically running processes in the ganglion cell layer (GCL) (but not in the cell bodies). At P14 (the 14th day after birth) a strong KAT I immunoreactivity was observed in M€ u uller cell endfeet. KAT II was expressed in the IPL, the FL, and in cells in the GCL at P1 and P7. From P14 on, KAT II expression in the IPL decreased. Double labeling revealed that KAT I was expressed in M€ u uller cell endfeet, whilst KAT II both on retinal ganglion cells (RGC) and M€ u uller cell endfeet.
Introduction
Kynurenine aminotransferases (KAT I and II) are pivotal to the synthesis of the tryptophan metabolite kynurenic acid (KYNA), the only known endogenous antagonist of glutamate (Perkins & Stone, 1982) and acetylcholine a7 nicotinic receptors (Hilmas et al., 2001) .
Investigations of KYNA synthesis are of particular interest because of its neuroprotective activity (Andine et al., 1988; Foster, Vezzani, French, & Schwarcz, 1984) . Importantly, KYNA has been suggested to modulate glutamate-mediated synaptogenesis and neurotransmission during brain development (Ceresoli-Borroni & Schwarcz, 2001) . Marked changes of brain KYNA concentrations were found prior to and following birth (Beal, Swartz, & Isacson, 1992) and during the development and aging processes in rodents (Moroni, Russi, Lombardi, Beni, & Carla, 1988) . Since glutamate receptors are already present at birth and show differences in spatial distribution and temporal expression in rat retinas Grunder, Kohler, Kaletta, & Guenther, 2000) it is conceivable that changes of KYNA availability might modulate the function of excitatory synapses (Carpendo et al., 2001) .
It is significant that KYNA was identified and quantified in the adult rat retina (Rejdak et al., 2002) in concentrations in the same range as those measured in the rat, rabbit and human brain (Moroni et al., 1988; Turski et al., 1988) . Recently, we reported that KYNA is present in both the vascular rat retina and the avascular chicken retina during development (Rejdak et al., 2001) .
Endogenous KYNA is produced by irreversible transamination of L L -kynurenine by KAT I and II (Guidetti, Okuno, & Schwarcz, 1997) . KAT I has been visibly demonstrated immunohistochemically in the rat brain Knyihar-Csillik, Okuno, & Vecsei, 1999; Roberts, Du, McCarthy, Okuno, & Schwarcz, 1992) , the medulla and the spinal cord (Kapoor, Okuno, Kido, & Kapoor, 1997) whereas KAT II was first identified by Northern blot mRNA analysis in the human brain (Okuno et al., 1990) . Immunohistochemical experiments using KAT I and II antibodies (Okuno, Nakamura, & Schwarcz, 1991; Okuno, Tsujimoto, Nakamura, & Kido, 1993) have shown that both enzymes are present in the inner retina of the adult rat (Rejdak et al., 2002) . Recently we showed that KAT I enzymatic activity changes during embryogenesis (Rejdak, Zielinska, Shenk, et al., 2003) .
Since it is established fact that KYNA is present in the vascularised rat and avascular chicken retina in high concentrations in early developmental stages and that its concentration decreases during aging (Rejdak et al., 2001) , this study was designed to investigate if those changes of the retinal KYNA synthesis are due to changes in the cellular expression of KAT I and II in the rat retina during development.
Material and methods
All experiments were performed in compliance with the guidelines of animal care in the European Community and the Association for Research in Vision and Ophthalmology.
Tissue preparation
Retinas from Brown Norway rats at different developmental stages between the first day of life and the adult stages were used in this study. The day of birth was designated as postnatal day 1 (P1). Rats were sacrificed with CO 2 . Eyes were removed, the anterior segments were dissected, and the eyecups were immersion-fixed for 30 min in 4% (wt./vol) paraformaldehyde in phosphate buffer (PB; 0.1 M, pH 7.4) at 4°C. After washing in PB, tissues were cryoprotected by immersion in 30% (wt./vol) sucrose in PB overnight at 4°C. Samples were embedded in cryomatrix (Leica, Heidelberg, Germany), cut vertically in 10-12 lm-thick sections using a cryostat, collected on gelatin-coated slides, air dried, and stored at )20°C for further use.
Immunohistochemistry
Endogenous peroxidase was blocked with 3% H 2 O 2 in 40% methanol; subsequently, sections were incubated for 1 h with 10% normal goat serum (NGS; Sigma, Munich, Germany) and 0.3% Triton X-100 in phosphate-buffered saline (PBST) to reduce background staining. Primary antibodies were diluted in PBST containing 10% NGS, for immunohistochemistry with antibodies against KAT I and II and incubated overnight at 4°C. KAT I and II were detected using either an anti-KAT I polyclonal antibody raised in rabbit against rat kidney KAT I or anti-human liver KAT II polyclonal antibody (primary antibodies) (Okuno et al., 1991 (Okuno et al., , 1993 .
Both antibodies were diluted to 1:50 in PBST. After washing with PBS, the samples were incubated for 1 h with the biotin-conjugated secondary antibody (dilution 1:200; Vectastain Elite Kit; Vector Laboratories, Burlingame, CA) in PBST with 5% NGS. After rinsing in PBS, retinal sections were processed with an avidinbiotin-peroxidase complex (Vectastain Elite Kit; Vector Laboratories) and stained with diaminobenzidine reaction products. For double labeling immunofluorescence, the preblocking step and primary antibodies incubation were performed in 20% NGS plus 2% bovine serum albumin (BSA, Sigma). Secondary antibodies (Molecular Probes; dilutions were 1:1000) were conjugated either to Alexa 568 (rabbit) or Alexa 488 (mouse).
A monoclonal antibody directed against glutamine synthetase was used as a marker for M€ u uller cells (Chemicon, dilution 1:500). To label RGC, the fluorescent tracer hydroxystilbamidine methanesulfonate (Fluorogold, Molecular Probes, Eugene, OR) was applied to each of the superior colliculi by stereotaxic injection 5 days before the rats were sacrified and processed for immunohistochemistry. Retinal control sections were processed as described above, with the first antisera omitted.
Results

KAT I expression
KAT I immunoreactivity was present from P1 on at all developmental ages studied, but showed different spatial distribution and temporal expression patterns ( Fig. 1) . On P1 and P7, KAT I expression was found from the border of the neuroblast layer to the vitreal border, i.e. in the developing IPL, the FL, and in processes ascending vertically through the GCL; the cell bodies of the GCL themselves were free of any staining. A strong KAT I immunoreactivity was observed in M€ u uller cell endfeet and processes surrounding the cells in the GCL, but, staining did not proceed beyond the GCL. The entire IPL showed a diffuse but pronounced immunoreaction. No staining was observed in the cells of the neuroblast layer. At P14 KAT I reached its final, adult distribution. At that time the neuroblast layer had differentiated into the layers of the mature retina, and this pronounced KAT I staining of the IPL was no longer visible; immunoreactivity was restricted to a small band of stained fibers at the border between the GCL and the IPL. KAT I immunoreactivity was observed in M€ u uller cell endfeet and their processes but did not extend beyond the GCL. There was no cellular staining in the neurons of the inner or outer retina (Fig. 1) . Fig. 1 . DAB labeling of KAT I in radial sections of the rat retina at different developmental stages (P1, P7, P14, P30, P90). The ganglion cell layer is oriented downwards. KAT I is expressed from P0 on at all developmental ages analyzed. At P1 and P7, KAT I is present from the border of the NL to the vitreal border, i.e. in the developing IPL, the GCL and the FL. Somata in the GCL were free of labeling. Strong KAT I immunoreactivity was observed in M€ u uller cell endfeet (black arrowhead) and their processes, but not beyond the GCL. At P14, KAT I reaches its final adult distribution, which can be also observed in the adult stages. KAT I staining is restricted to a small band of stained fibres at the border between the GCL and the IPL, while the IPL itself is no longer labeled. There is no cellular staining in neurons of the inner or outer retina. NBL, neuroblastic layer; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bar ¼ 20 lm. . DAB labeling of KAT II in radial sections of the rat retina at different developmental stages (P1, P7, P14, P30, P90). The ganglion cell layer is oriented downwards. KAT II was expressed from P1 on at all developmental ages studied. At P1 and P7 there was labeling of cells in the IPL, the GCL and the FL. Entire cells in RGC layer are uniformly stained (white arrows). During aging, a continuous decrease of KAT II expression was observed. At P90, the most intense labeling was present at the bottom of the cells where the nerve fibres leave the cell (black arrow). No staining was visible in either the IPL or the outer retina. Scale bar ¼ 20 lm. NBL, neuroblastic layer; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer. Scale bar ¼ 20 lm. Double labeling with KAT I and glutamine synthetase antibody in adult rat retina demonstrated the expression of KAT I in the endfeet of M€ u uller cells. We observed clear double labeling in the endfeet; this stopped at the border between IPL and RGC layer. There was no KAT I staining in the distal parts of M€ u uller cells (Fig. 2) .
Staining of KAT I after retrograde labeling of RGC showed that the cellular expression of KAT I was restricted to M€ u uller cell endfeet. It was clearly separated from the RGC. Additionally, KAT I was found only in barely detectable amounts in parts of M€ u uller cells distal to IPL. The trunks of M€ u uller cells were also stained. There was a faint staining in the border between the RGC and the IPL. KAT I staining seemed to surround cells in the GCL, forming ring-like structures (Fig. 3) .
KAT II expression
KAT II was expressed from P1 on at all developmental ages studied and showed different patterns of spatial distribution and temporal expression (Fig. 4) .
Application of the antibody against KAT II in early postnatal stages P1 and P7 resulted in strong labeling of cells in the IPL, RGC and nerve fibre layer. Entire cells in the GCL were uniformly stained. During aging, KAT II expression decreased continuously. At P90, the most intense labeling was present at the vitreal pole of the somata in the GCL where the nerve fibres leave the cell. No staining was observed in either the IPL or the outer retina (Fig. 4) .
Additionally, double labeling with KAT II antibody and glutamine synthetase antibody also showed KAT II expression in the M€ u uller cell endfeet in adult rat retina. (Fig. 5) .
Staining of KAT II after retrograde labeling of RGC showed that cellular expression of KAT II was present both on the RGC and in M€ u uller cell endfeet (Fig. 6) .
No staining was observed in either of the controls.
Discussion
The study described here shows that both KAT I and II are present in the rat retina during differentiation, and that the two enzymes display different patterns of spatial distribution and temporal expression. The pronounced expression of both enzymes in early developmental stages generally paralleled our previous results showing that KYNA, the product of both enzymes, was present in both vascularised rat and avascular chicken retinas during development. In rats, the retinal KYNA concentration peaked at birth and decreased markedly during the first 2 weeks of life. A similar time course of KYNA content was observed in chicken retinas (Rejdak et al., 2001) . A high level of expression of KAT I and II in the retina occurs almost exclusively within the first two postnatal weeks and may be related to processes of synapse formation in the retina. It may also play an important neuromodulatory role in the retina during development. At the time of eye opening, about P15-P17, the expression patterns of KAT I and II are already very similar to those observed in adult retinas.
Studies of age-related changes of KATs activity in the rat brain demonstrate a marked heterogeneity of enzymatic changes between regions. A significant increase of KAT activity in the cortex, the hippocampus and the striatum between the ages of 3 and 24 months was observed, while in the thalamus and the cerebellum changes were much less pronounced in adult rats, and a decrease was found in old animals (Gramsbergen, Schmidt, Turski, & Schwarcz, 1992) . Results of the present study seem to indicate that age-related changes of KATs expression are specific for brain structures.
It has been suggested that changes of KYNA availability may modulate the function of excitatory synapses (Carpendo et al., 2001) . The sensitivity of NMDA receptors undergoes discrete changes during differentiation, and regional differences exist with regard to the properties of NMDA receptors in both the developing and the adult brain (McDonald & Johnston, 1990 ). Since glutamate receptors, which are preferential targets of KYNA, are already present at birth and show differences in spatial distribution and temporal expression in the rat retina Grunder, Kohler, Kaletta, et al., 2000) developmental changes of KATs and KYNA content may play a role in glutamate-mediated neurotransmission during differentiation.
It was recently documented that excitatory amino acid antagonists can trigger apoptosis in the developing mammalian brain (Olney et al., 2002) and that KAT I plays a role in the regulation of programmed cell death (Csillik, Okuno, Csillik, Knyihar, & Vecsei, 2002) . In light of this, it is conceivable that KAT and KYNA may control apoptosis in the retina during early development.
The decrease of cellular expression of both KATs found in our study during postnatal life may also be explained by a significant increase in the total rat retinal content of glutamate during the postnatal period, synchronous with the generation and maturation of glutamatergic cells (Haberecht & Redburn, 1996) . Data exist showing that glutamate diminishes KYNA synthesis in brain slices, and a regulatory influence on endogenous KYNA concentration has been suggested (Urbanska, Chmielewski, Kocki, & Turski, 2000) . Also, evidence is accumulating that cerebral KYNA synthesis is exceptionally amenable to modulation by dopaminergic mechanisms during the early postnatal period (Schwarcz, Poeggeler, Rassoulpour, Ceresoli-Borroni, & Hodgkins, 1998) . Whether dopamine regulates the expression of KATs in the developing retina remains to be determined.
Our results of double labeling studies show that KAT I is preferentially expressed in M€ u uller cell endfeet, while KAT II is localized in both M€ u uller cell endfeet and in retinal ganglion cells (RGC). These findings are in agreement with our previous results showing that in the chicken retina KAT I is expressed in M€ u uller cell endfeet (Rejdak, Zielinska, Shenk, et al., 2003) . KAT II, which in contrast to KAT I has a pH optimum in the physiological range (Okuno et al., 1990) , is responsible for most KYNA formation under physiologic conditions (Guidetti et al., 1997) . In the rat hippocampus KAT immunoreactivity was found mainly in glial cells while in the striatum it was observed in both glial cells and neurons (Roberts et al., 1992) . Kapoor et al. (1997) reported predominantly neuronal KAT localization in the ventral medulla, the nucleus ambiguus, the nucleus of the solitary tract, and the intramediolateral cell column of the spinal cord. They also found that KAT staining appeared to be diffuse in astrocytes but punctate in neurons (Kapoor et al., 1997) . This pattern was similar to that observed in other studies (Okuno et al., 1991; Du et al., 1992) . In contrast, in our study both M€ u uller cell endfeet and the cytoplasm of the cells in the ganglion cell layer were uniformly stained.
It has been suggested that a deficiency of KYNA synthesis is causally related to the pathology of excitotoxic brain diseases (Schwarcz et al., 1998) . Recently, we reported alterations of KYNA content in the retina in response to NMDA-induced RGC damage . Importantly, it has been found that exposure to the mitochondrial toxins induces depletion of KAT I cellular expression in the rat brain. The authors suggested that a decrease of KAT expression in the brain may directly contribute to mechanisms of neuronal degeneration (Csillik et al., 2002; Knyihar-Csillik et al., 1999) .
Further studies on the role of KAT I and II in glutamate transmission using pharmacological modulation of KYNA synthesis or knockout mice models (developed in the future) are recommended. Possibly the KAT I and II might be differently expressed in the various retinal degeneration models and the time course of their neuromodulatory effects can be followed in such models.
Conclusion
KAT I and II were found in the inner retina. Expression of KAT I was restricted to M€ u uller cell endfeet, while KAT II immunoreactivity was found in both M€ u uller cell endfeet and the RGC. Since the high cellular expression of KAT I and II occur almost exclusively within the first two postnatal weeks, we suggest that KAT is related to the process of synapse formation in the retina and may play an important neuromodulatory role in the retina during development.
